Free NPI Number Lookup with the Official NPI Registry

Dr. Marcy Verplanck-Kanitz

Home >Dr. Marcy Verplanck-Kanitz

 

NPI Number Detailed Information

Provider Information:

Name: Dr. Marcy Verplanck-Kanitz
Gender: F
Provider License Number If Given: 5101009923

NPI Information:

NPI: 1245282631
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 5/16/2006

Last Update Date: 11/24/2020

Reputation Report:

Provider Business Mailing Address:

Address: 1200 6TH ST STE 400
Traverse City, MI 49684
Phone Number: 2313920650
Fax Number: 2313920665

Provider Business Practice Location Address:

Address: 1200 6TH ST STE 400
Traverse City, MI 49684
Phone Number: 2313920650
Fax Number: 2313920665

Provider Taxonomy:

Primary: 207VX0000X
Secondary (if any):
State: MI

Top Doctors in MI

 

About Dr. Marcy Verplanck-Kanitz

Dr. Marcy Verplanck-Kanitz (DR. MARCY VERPLANCK-KANITZ ) is Definition Obstetrics & Gynecology Physician in Traverse City, MI. The NPI Number for Dr. Marcy Verplanck-Kanitz is 1245282631.
The current location address for Dr. Marcy Verplanck-Kanitz is 1200 6TH ST STE 400 Traverse City, MI 49684 and the contact number is 2313920650 and fax number is 2313920665. The mailing address for Dr. Marcy Verplanck-Kanitz is 1200 6TH ST STE 400 Traverse City, MI 49684- 2313920650 (mailing address contact number - 2313920650).
Definition to come...

Provider Business Location on Map

FAQs:

What is the NPI Number for Dr. Marcy Verplanck-Kanitz ?


Answer: The NPI Number for Dr. Marcy Verplanck-Kanitz is 1245282631

Where is Dr. Marcy Verplanck-Kanitz located?


Answer: Dr. Marcy Verplanck-Kanitz is located at 1200 6TH ST STE 400 Traverse City, MI 49684.

What is the specialty for Dr. Marcy Verplanck-Kanitz ?


Answer: The Specialty of Dr. Marcy Verplanck-Kanitz is Definition Obstetrics & Gynecology Physician.

Are there any online reviews for Dr. Marcy Verplanck-Kanitz ?


Answer: Yes! Check It Now.

Are there any other health care providers in Traverse City, MI?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Marcy Verplanck-Kanitz

Number of HCPCS 22
Number of Medicare Beneficiaries 53
Number of Services 86
Total Submitted Charge Amount 18716
Total Medicare Allowed Amount 10755.25
Total Medicare Payment Amount 7929.54
Total Medicare Standardized Payment Amount 8127.51
Drug Suppress Indicator *
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator #
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries 65
Number of Beneficiaries Age Less 65 14
Number of Beneficiaries Age 65 to 74 26
Number of Beneficiaries Age 75 to 84
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries 53
Number of Male Beneficiaries 0
Number of Non-Hispanic White Beneficiaries
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement 15
Number of Beneficiaries With Medicare Only Entitlement 38
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia
Percent (%) of Beneficiaries Identified With Asthma
Percent (%) of Beneficiaries Identified With Cancer
Percent (%) of Beneficiaries Identified With Heart Failure
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease
Percent (%) of Beneficiaries Identified With Depression 0.32
Percent (%) of Beneficiaries Identified With Diabetes
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.42
Percent (%) of Beneficiaries Identified With Hypertension 0.4
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease
Percent (%) of Beneficiaries Identified With Osteoporosis
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.32
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries 0.7463

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Obstetrics & Gynecology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 174
Number of Standardized 30-Day Fills 331.36666667
Aggregate Cost Paid for All Claims 12198.64
Number of Day's Supply for All Claims 8803
Number of Medicare Beneficiaries 61
Number of Claims, Including Refills, for Beneficiaries Age 65+ 157
Including Refills, for Beneficiaries Age 65+ 300.9
Beneficiaries Age 65+ 11568.29
Number of Day's Supply for All Claims for Beneficaries Age 65+ 8029
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 22
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 152
Aggregate Cost Paid for Generic Drugs 6995.12
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 54
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 2198.31
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 120
Aggregate Cost Paid for Claims Filled by 10000.33
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 35
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 3462.99
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 139
by Low-Income Subsidy 8735.65
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including 14
Aggregate Cost Paid for Antibiotic Drugs 151.12
Antibiotic Claims 12
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries 69.573770492
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries 61
Number of Male Beneficiaries 0
Number of Non-Hispanic White 60
Number of Black or African American
Number of Asian Pacific Islander 0
Number of Hispanic Beneficiaries 0
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category 0.8762704918

More Providers in traverse-city , mi

Dr. marcy verplanck-kanitz in Other Directories

Provider don't have other directory link yet.